These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3426700)
41. Aldehyde dehydrogenase inhibitors and voluntary ethanol drinking by rats. Sinclair JD; Lindros KO; Terho K Adv Exp Med Biol; 1980; 132():481-7. PubMed ID: 7424727 [TBL] [Abstract][Full Text] [Related]
42. The ethanol metabolite acetaldehyde induces water and salt intake via two distinct pathways in the central nervous system of rats. Ujihara I; Hitomi S; Ono K; Kakinoki Y; Hashimoto H; Ueta Y; Inenaga K Neuropharmacology; 2015 Dec; 99():589-99. PubMed ID: 26298003 [TBL] [Abstract][Full Text] [Related]
43. Cyanamide given ICV or systemically to the rat alters subsequent alcohol drinking. Critcher EC; Myers RD Alcohol; 1987; 4(5):347-53. PubMed ID: 3675855 [TBL] [Abstract][Full Text] [Related]
44. Further studies on the potential contribution of acetaldehyde accumulation and oxidative stress in rat mammary tissue in the alcohol drinking promotion of breast cancer. Fanelli SL; Maciel ME; Díaz Gómez MI; Delgado de Layño AM; Bietto FM; Castro JA; Castro GD J Appl Toxicol; 2011 Jan; 31(1):11-9. PubMed ID: 20623749 [TBL] [Abstract][Full Text] [Related]
45. Age dependent development of ethanol drinking in rats after inhibition of aldehyde dehydrogenase. Barwick VS; Myers RD Alcohol; 1992; 9(6):501-7. PubMed ID: 1472305 [TBL] [Abstract][Full Text] [Related]
46. Brain ethanol-metabolizing enzymes are differentially expressed in lead-exposed animals after voluntary ethanol consumption: Pharmacological approaches. Mattalloni MS; Deza-Ponzio R; Albrecht PA; Fernandez-Hubeid LE; Cancela LM; Virgolini MB Neurotoxicology; 2019 Dec; 75():174-185. PubMed ID: 31550440 [TBL] [Abstract][Full Text] [Related]
47. Effect of acetaldehyde on ethanol absorption in the canine jejunum. Shinohara T; Ijiri I; Fuke C; Kiriu T; Ameno K Arukoru Kenkyuto Yakubutsu Ison; 1992 Oct; 27(5):519-27. PubMed ID: 1449411 [TBL] [Abstract][Full Text] [Related]
48. Characteristics of aldehyde dehydrogenases of certain aerobic bacteria representing human colonic flora. Nosova T; Jokelainen K; Kaihovaara P; Heine R; Jousimies-Somer H; Salaspuro M Alcohol Alcohol; 1998; 33(3):273-80. PubMed ID: 9632053 [TBL] [Abstract][Full Text] [Related]
49. Studies on ethanol-brain catalase interaction: evidence for central ethanol oxidation. Aragon CM; Stotland LM; Amit Z Alcohol Clin Exp Res; 1991 Mar; 15(2):165-9. PubMed ID: 2058789 [TBL] [Abstract][Full Text] [Related]
50. Demonstration of a functional blood-testis barrier to acetaldehyde. Evidence for lack of acetaldehyde effect on ethanol-induced depression of testosterone in vivo. Anderson RA; Quigg JM; Oswald C; Zaneveld LJ Biochem Pharmacol; 1985 Mar; 34(5):685-95. PubMed ID: 3977944 [TBL] [Abstract][Full Text] [Related]
51. The effect of inhibition of aldehyde dehydrogenase on nasal uptake of inspired acetaldehyde. Stanek JJ; Morris JB Toxicol Sci; 1999 Jun; 49(2):225-31. PubMed ID: 10416267 [TBL] [Abstract][Full Text] [Related]
52. Formation of the 37KD protein-acetaldehyde adduct in liver during alcohol treatment is dependent on alcohol dehydrogenase activity. Lin RC; Lumeng L Alcohol Clin Exp Res; 1990 Oct; 14(5):766-70. PubMed ID: 2264608 [TBL] [Abstract][Full Text] [Related]
53. Michaelis-Menten elimination kinetics of acetaldehyde during ethanol oxidation. Fujimiya T; Yamaoka K; Ohbora Y; Aki T; Shinagawa H Alcohol Clin Exp Res; 2002 Aug; 26(8 Suppl):49S-54S. PubMed ID: 12198375 [TBL] [Abstract][Full Text] [Related]
54. Blood acetaldehyde levels in alcohol-dosed rats after treatment with ANIT, ANTU, dithiocarbamate derivatives, or cyanamide. García de Torres G; Römer KG; Torres Alanis O; Freundt KJ Drug Chem Toxicol; 1983; 6(4):317-28. PubMed ID: 6413190 [TBL] [Abstract][Full Text] [Related]
55. Studies on the cyanamide-ethanol interaction. Dimethylcyanamide as an inhibitor of aldehyde dehydrogenase in vivo. Shirota FN; DeMaster EG; Nagasawa HT Biochem Pharmacol; 1982 Jun; 31(11):1999-2004. PubMed ID: 7115421 [TBL] [Abstract][Full Text] [Related]
56. Effects of high hepatic acetaldehyde level following simultaneous administration of ethanol and cyanamide on liver function in rats. Nakatsukasa H; Watanabe A; Kobayashi M; Hobara N; Fujiwara M; Yamauchi Y; Shiota T; Higashi T; Nagashima H Res Exp Med (Berl); 1985; 185(3):221-5. PubMed ID: 4023431 [TBL] [Abstract][Full Text] [Related]
57. Drinking patterns in genetic low-alcohol-drinking (LAD) rats after systemic cyanamide and cerebral injections of THP or 6-OHDA. West MW; Biggs TA; Tavares E; Lankford MF; Myers RD Alcohol; 1998 Apr; 15(3):239-47. PubMed ID: 9539382 [TBL] [Abstract][Full Text] [Related]
58. Blood acetaldehyde and the ethanol-induced increase in splanchnic circulation. Carmichael FJ; Israel Y; Saldivia V; Giles HG; Meggiorini S; Orrego H Biochem Pharmacol; 1987 Aug; 36(16):2673-8. PubMed ID: 3606666 [TBL] [Abstract][Full Text] [Related]
59. Selective suppression of schedule-induced ethanol drinking by antialcoholic drugs in rats. Kuribara H; Higashida A; Tadokoro S Jpn J Pharmacol; 1984 Jun; 35(2):123-8. PubMed ID: 6748375 [TBL] [Abstract][Full Text] [Related]
60. Developmental lead exposure induces opposite effects on ethanol intake and locomotion in response to central vs. systemic cyanamide administration. Mattalloni MS; Deza-Ponzio R; Albrecht PA; Cancela LM; Virgolini MB Alcohol; 2017 Feb; 58():1-11. PubMed ID: 28109342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]